Background/Aims: Bone marrow Mesenchymal stem cells (MSCs) are promising for promoting cutaneous wound healing through reinforcing cellular processes. We evaluated the effect of GFP-tagged MSCs transplantation on skin regeneration in excisional wounds in mice. Methods: MSCs from GFP-labeled transgenic mice were co-cultured with acellular dermal matrix (ADM) scaffolds, and MSC-ADM scaffolds were transplanted into surgical skin wounds of BALB/c mice. After implantation, the survival and behavior of MSCs were examined by second harmonic generation and two-photon excitation fluorescence imaging, western blotting and DNA amplification and sequencing. Results: GFP-tagged MSCs were retained inside the regenerating skin until day 14 post-transplantation. Alpha-smooth muscle actin (α-SMA) and vimentin (VIM) were detected at 3, 5, 7, and 14 days post-transplantation by immunofluorescence double labeling. Although the GFP + /α-SMA + -and GFP + /VIM + -cell numbers decreased gradually with healing time, α-SMA + -and VIM + -cell numbers significantly increased, most of them were endogenous functional cells which were related to angiogenesis and collagen fiber structural remodeling. Conclusion: Therefore, in the initial stage of wound healing, transplanted MSCs differentiated into functional cells and played paracrine roles to recruit more endogenous cells for tissue remodeling. With the disappearance of exogenous cells, endogenous cells were responsible for the latter stage of cutaneous wound healing.
Activities of MSCs Derived from Transgenic

Introduction
Mesenchymal stem cells (MSCs) derived from extensive sites in adult, perinatal, or fetal tissues are considered alternative candidates for cell-based regenerative therapy due to their potential influence on the wound microenvironment. In dermatology, various of molecules
TPEF-SHG imaging of ADM and MSC-ADM grafts in vitro
The MSC-ADM scaffolds were gently washed in PBS to remove dead and non-adherent cells, fixed in 10% formalin, stained with 4',6-diamidino-2-phenylindole (DAPI,,28718-90-3,sigma, USA) for 15 min and washed 5 times with PBS to observe the nuclei of the MSCs. Images of the grafts were taken by a two-photon laser scanning confocal microscope (TPLSCM, LSM 710 NLO, Carl Zeiss, Jena, Germany) using the stack scan with the laser (Coherent, Santa Clara, CA, USA) at wavelengths of 720 nm (DAPI imaging), 850 nm (GFP imaging) and 820 nm (collagen imaging). The imaging system scanned the ADM and MSC-ADM scaffolds continually, and a series of focal planes were obtained along the Z axis with a 1-µm step size. GFP, DAPI and collagen imaging were performed in each of the three-dimensional image acquisition experiments.
Excision wound model and MSC-ADM implantation
A full-thickness, 7-mm-diameter skin wound was sheared on the middle dorsum of anesthetized male BALB/c mice (8-10 week) using a biopsy punch. Then, the MSC-ADM scaffolds were transplanted into the wounds of the recipient mice. We removed the excess liquid components around the wound with filter paper and covered the wound area with Comfeel transparent dressing. Finally, the wound was wrapped with medical adhesive tape. The wounds in control group meant no any treatment of ADM scaffold and MSCs, besides the usage of Comfeel transparent dressing and medical adhesive tape.
TPEF-SHG imaging of MSC-ADM transplanted into the wound site ex vivo
Mice were anesthetized with chloral hydrate solution after treatment for 3, 5, 7 and 14 days. The cutaneous wound repair areas were disinfected with alcohol and dissected from the mice, flattened and placed on clean glass slides. These tissue samples were imaged in stack scan mode by TPLSCM with a laser at wavelengths of 850 nm (GFP imaging) and 820 nm (collagen imaging). During the imaging process, the inner side of the wound areas in each sample were scanned continuously (a frame of a 2D image) for collagen and GFP simultaneously at a speed of 10 s per frame. To ensure the selected tissue samples were alive, the exposure time of the samples was limited to within 30 min. The intensities of the SHG signals were collected and analyzed using Image J software.
Western Blotting
Eight organs from the transgenic mouse were lysed in radioimmunoprecipitation assay (RIPA) buffer and PMSF. The total proteins were resolved by SDS-PAGE, then transferred onto immunoblot membranes [poly (vinylidene difluoride)]. According to the instructions of Marker molecular weight, immunoblot membranes were cut into two parts, one of which contains GFP, another contains GAPDH. The membranes were blocked in 5% skim milk at 4°C overnight and incubated with rabbit monoclonal GFP antibody (1:2000 dilution, Millipore Chemicon, Billerica, MA, USA) and mouse monoclonal GAPDH antibody (1:2000 dilution, CW0100A, cwbiotech, Beijing, China) at 4°C overnight. After washing the blots three times with TBS-buffered saline with 0.05% Tween-20 (TBST), they were incubated with secondary antibodies for horseradish peroxidase (HRP)-conjugated goat anti-rabbit GFP IgG (1:3000 dilution, CW0103, cwbiotech, Beijing, China) and goat anti-mouse GAPDH IgG (1:3000 dilution, CW01025, cwbiotech, Beijing, China) at room temperature for two hours. The blots were washed three times and visualized using a 3, 3'-diaminobenzidine (DAB) system (CW0125B, Qiyun Biotechnology, Guangzhou, China). The membranes were scanned and photographed using an MP ChemiDoc versatile gel imaging analysis system. Signal intensity was quantified and analyzed using a Quantity One analysis system (Bio-Rad).
mRNA expression by real-time quantitative PCR
The organs of the transgenic mice were ground and washed three times in warm PBS. Then, the total RNA was extracted from the tissues using RNAiso Plus (D9108A, Bao Biological Engineering, Dalian, China) and purified by DNase treatment. RNA was converted to cDNA, and quantitative real-time PCR was performed according to the manufacturer's instructions (Applied Biosystems 7500). The q-PCR primer sequences were as follows: green fluorescent protein (GFP) forward 5'-GCACGACTTCTTCAAGTCCGCCATGCC-3', reverse 5'-GCGGATCTTGAAGTTCACCTTGATGCC-3'. Reactions were performed using SYBR Green PCR master mix in a Bio-Rad iCycler iQ Detection System. The expression levels of the mRNA of GFP genes were normalized according to the reference gene ACTB. Normalization and fold changes were calculated using the ΔΔCt method [34] . The skin of normal healthy mice was used as a control group. Five repetitions were performed on each sample. 
DNA amplification and product identification
Skin samples were harvested on the 14, 21, and 28 days after treatment. The total DNA of these samples was extracted by using a TIANamp Genomic DNA kit (N1141, Dongsheng Biotech, Guangzhou, China). The content and purity of the extracted DNA were measured using an Ultra Micro spectrophotometer. The DNA was amplified with the following GFP primers: forward 5'-GCACGACTTCTTCAAGTCCGCCATGCC-3', reverse 5'-GCGGATCTTGAAGTTCACCTTGATGCC-3', in a 25-μL reaction mixture containing 2.5 µL PCR buffer, 4.0 µL dNTP, 0.5 µL Mg2+, 1.0 µL template DNA, 0.25 µL Taq enzyme, 1.0 µL each of upstream and downstream primers, and 14.75 µL Sterile distilled water (dd H2O). The cycling parameters were as follows: predenaturation at 95°C for 3 min; 35 cycles of denaturation at 95°C for 45 s, annealing at 50°C for 45 s, and extension at 72°C for 45 s; full extension at 72°C for 10 min and holding at 4°C until the end. After the PCR amplification reaction, a 4-µL amplification product was mixed with 1 µL 10× loading buffer, loaded onto 1% agarose gels, and electrophoresed for 15 min under 135 V. Then, the gels were photographed using a gel imaging system. Marker D2000 was used as a standard reference to determine the size of the amplified DNA products. Finally, the PCR products were sent to Meiji Biological Engineering Co. Ltd. (Shanghai, China) for DNA sequencing.
Histological and immunofluorescent analysis
Wound samples were fixed in 4% polyformaldehyde at 4°C for 24 h and then sectioned perpendicularly into 4 μm paraffin sections. The paraffin sections were stained with hematoxylin and eosin (H & E) for histological analysis of wound healing. Masson staining was also performed to analyze the growth status of the regenerated tissue collagen fibers during wound healing. To determine the source of GFP-positive cells in the regenerated tissues, we used double-labeled immunofluorescence staining. α-SMA, vimentin, and GFP antibodies (1:1000, Millipore Chemicon, Billerica, MA, USA) were used to detect endothelial cells and fibroblast cells. GFP was visualized with an FITC-conjugated secondary antibody (1:100, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Smooth muscle cells of blood vessels (VSMCs) and fibroblast cells were identified with a Rhodamine-labeled secondary antibody (1:100, KPL, Gaithersburg, MD, USA). Nuclei were labeled by exposure to DAPI for 15 min. Untreated group without ADM and MSCs was served as the control group. Wound samples in control group were processed with the same double-labeled immunofluorescence staining. Images were obtained with a Zeiss LSM 510 confocal microscope (Carl Zeiss, Jena, Germany). Capillary density was evaluated by examining three random fields of each section (n = 5) after immunofluorescence staining of VSMCs with the α-SMA antibody. The fluorescence intensity of the vimentin antibody represents the fibroblast content [35] . Fluorescence intensity was processed and analyzed by Image J.
Statistical analysis
The experimental data were presented as the mean ± SD. Statistical analysis was performed using SPSS19.0 statistical software. The differences between two groups were evaluated using unpaired Student's t tests. Values of P<0.05 were considered statistically significant.
Results
Stable expression of GFP fluorescence in mice
Although it was expensive and complicated to obtain GFP+-MSCs from transgenic mice, we considered this MSC line to be the best candidate for the current study due to their stable retention of the GFP tag during the entire developmental period of the transgenic mice. The transgenic mice we used showed obvious fluorescence characteristics when they were imaged using a live imaging apparatus (Fig. 1A) . Eight different organs were removed (Fig. 1B) , and the expression of GFP in these organs was evaluated by q RT-PCR and western blotting. The results indicated that GFP fluorescent signals were detected in all organs ( Fig.  1C) and that the level of GFP expression was highest in the liver ( Fig. 1D and E).
Characterization of MSCs
After five passages, MSCs were imaged under light and fluorescence microscopes ( Fig.  2A and 2B ). The cells clearly exhibited normal spindle-shaped morphologies and strong fluorescence characteristics. Fluorescence-activated cell sorting (FACS) analysis of the MSCs indicated that they were negative for CD45, CD34 and CD14, but strongly expressed typical surface antigens, such as CD29, CD90, CD105 and CD44 (Fig. 2C) .
Characterization of acellular scaffold
After removing the epidermis and cellular components from the dermis of the skin collected from ten-week-old mice, we obtained white, round and porous acellular scaffolds. (Fig. 3A) . SEM imaging of the ADM scaffolds showed that the acellular scaffolds were composed of distributed fibrous structures and that the fibers were arranged in a net shape, forming a gap of different sizes (Fig. 3B) . Single ADM scaffolds and MSC-ADM scaffolds were imaged by TPLSCM (Fig. 3C and D) . The MSCs survived and grew well on the scaffolds. The MSCs gradually invaded deeper layers of the acellular dermal scaffolds with prolonged culture time (white arrows).
Skin wound modeling and wound repair analysis
The process of establishing the mouse skin wound model is illustrated in Fig. 4A . Male BALB/c mice (8-10 weeks old) were anesthetized by intraperitoneal injection of chloral hydrate solution. After the mice were completely anesthetized, they were fixed on an operating table, and a circular area with a diameter of 7 mm was marked on the backs of the mice. Then, a full-thickness cutaneous wound was made on the selected circular area using a biopsy punch with ophthalmic scissors and tweezers. The wounds were treated with wound closure was 91.9 ± 2.5% in MSC-ADM group and 83.1 ± 2.0% in control group at postoperative 28 days.
Dynamic change in MSCs during wound healing revealed by TPEF-SHG imaging analysis and western blotting
To observe the behavior of MSCs during wound repair, regenerative skin tissues located at the wound sites were collected on days 3, 5, 7 and 14 after MSC-ADM scaffolds were implanted into the skin wounds and immediately imaged by TPLSCM. In addition, the wounds of control group were also imaged by TPLSCM (Fig. 5A) . By evaluating the GFP and SHG signal intensities of the corresponding samples from the photographs shown in Fig. 5A , we obtained two curves to depict the changes of the number of MSCs and collagen accumulation at different time points (Fig. 5C and Fig. 5B ). The result revealed that the collagen content markedly increased in both two groups as treatment time was prolonged and the content of MSC-ADM group was higher than that of control group at the same healing day (Fig. 5B) . The number of GFP+-MSCs gradually decreased ( Fig. 5C ) with time. This result was further confirmed by western blot analyses (Fig. 5D and 5E ). The expression level of GFP was significantly decreased in the wounds and approached zero on days 14 after wound induction.
Dynamic change in MSCs during wound healing revealed by PCR analysis
To determine the cause of the disappearance of fluorescent signals in previous experiments, whether due to gene silencing or cell apoptosis, we extracted the genomic DNA from healing tissues and amplified the GFP gene sequence from these DNA samples (Fig. 6A) . PCR results showed that Lanes 1 to 4 (day 3 to 14) had bright target bands corresponding to a size of approximately 260 bp. However, Lane 5 (day 21) and Lane 6 (day 28) had no target bands. The brightness of the target band became weaker with time. The relative content of DNA also presented a gradually decreasing trend (Fig. 6B) . Strip brightness (relative DNA content) on days 5, 7, 14, 21, and 28 were calculated relative to that on day 3. The PCR products of the bands were sequenced, and base peak maps are displayed (Fig. 6C) . The PCR products were sequenced in the forward and reverse directions. The size of the coding sequence of the target gene was 720 bp. Comparing the results of sequencing with the GFP coding sequence, the base sequence of the amplified product corresponded to approximately the 250th to 500th bp of the GFP coding sequence. Base sequence alignment was performed using CLUSTALX2 software (Fig. 6D) . The forward and reverse sequences were each compared with the GFP coding sequence. The matching rate reached 98% (white blank blocks indicate no match of the bases). Thus, the DNA amplification products before day 14 were GFP. This result revealed that the GFP gene was still present on day 14, indicating that the MSCs (or the MSCs and their differentiated progeny) were alive. On days 21 and 28, the GFP gene was not detected, indicating that the fluorescent cells had undergone apoptosis.
Collagen regeneration and skin remodeling
Masson staining can provide general information and insight regarding the wound healing process after transplantation. As shown in Fig. 7A , sections of the wound site showed a loss of full-thickness skin. In the first few days, we observed the wounds of MSC-ADM group under a microscope that a dyed red scab formed in the wound. However, the accessory glands and the muscle layer did not appear in the wound. On day 14, with the disappearance of the scab, the wound skin had become smoother, and the regeneration of collagen was also more obvious. On day 21, skin appendages, the most significant development in the process of skin healing, were reborn in the wound. On day 28, the regenerative tissue more closely resembled normal skin. However, the regeneration structure of wounds in control group was relatively incomplete and the repair rate is comparatively slow. A collagen regeneration reaction was analyzed by double-immunofluorescence staining with fibroblast cytoskeletal protein (vimentin/VIM) and GFP (Fig. 7B) . In the MSC-ADM group, we observed many GFP + /VIM + -cells at the wound site three days after operation, whereas the number of these cells decreased with treatment time. On day 7, a very small amount of green fluorescent protein was detected, and GFP became fuzzy and non-morphological. Almost no GFP could be detected on day 14 ( Fig. 7B and C) . The survival rate of the implanted MSCs was determined by measuring the fluorescence intensity of the cells. The relative number of fibroblasts derived from the MSCs gradually reduced; this process was accompanied with the proportion of GFP + /VIM + -cells and the total VIM + -cells decreased gradually. Furthermore, the endogenous fibroblast population increased (Fig. 7C) , which indicated that paracrine effects slowly played a leading role as the time of wound healing increased. However, compared with the control group, the expression levels of VIM were higher in the MSC-ADM group (Fig. 7D) , and this result demonstrated that the MSC-ADM played a role in the recruitment and secretion processes during wound repair. For each detection time point, the expressions of VIM continuously increased from day 3 to day 14 in the MSC-ADM and control groups, and this change was consistent with the increasing number of fibroblasts in regenerating tissues. 
Angiogenesis response in the wound
As an important part of the healing process, the angiogenesis response was analyzed by double-immunofluorescence staining with Alpha-smooth muscle actin (α-SMA) and GFP. The control group was only stained with α-SMA antibody. (Fig. 8A) . Three days after cell transplantation, we observed GFP (Fig. 8B) . In addition, we also observed that the number of smooth muscle cells of blood vessels (VSMCs) that differentiated from the MSCs decreased but the number of endogenous VSMCs was increased. In addition, the proportion of GFP + /α-SMA + -cells and the total number of α-SMA + -cells gradually decreased in the MSC-ADM group (Fig. 8B) . The results demonstrated that paracrine effects played a major role in the wound healing process. Immunofluorescence staining showed a gradual increase in the expression of α-SMA in the wound sites on days 3, 5, 7 and 14. α-SMA expression was higher in the MSC-ADM group than in control group (Fig. 8C) .
Discussion
In the clinical treatment of acute wounds or chronic lesions of the skin, MSCs represent a promising opportunity, and a better understanding of MSC-mediated improvements in cutaneous repair are needed for clinical success. In the present study, we used ADM scaffolds containing GFP-tagged MSCs extracted from the bone marrow of transgenic mice to treat excisional wounds in a mouse model. Combining traditional biomedical detection techniques with an advanced optical imaging modality, we analyzed the effects and activities of MSCs during the wound-healing process.
Based on their self-renewal and multi-lineage differentiation potentials, MSCs have been confirmed to possess the capacity to improve the wound-healing process in several damaged tissues. To understand this process in detail and to ensure safety and efficacy, it is crucial to detect the fate and distribution of MSCs delivered to wound sites. GFP has already become the most suitable biomarker for tracking MSCs due to its biocompatibility, safety, nontoxicity and high detectability [36, 37] . GFP-tagged MSCs derived from transfection methods have been commonly used as donor cell sources in previous studies [36, 38, 39] . Previous results demonstrated that GFP-tagged MSCs could be traced for 4 weeks after surgical treatment [36] . In consideration of the above-mentioned findings, we used this strategy in our previous work [30] and found that almost no GFP fluorescent signals could be detected at 14 days after transplantation. Although GFP labelling of transfected MSCs can be maintained for several months in culture in vitro, we were unsure what had occurred when these MSCs were applied in real animal models. Using a gene recombination technique, the GFP gene was recombined into the mouse genome at an early embryonic stage and was stably expressed in several tissues and organs until the embryos developed to adult founders (Fig. 1A) . Therefore, in our present work, MSCs extracted from the bone marrow of transgenic mice were selected as a candidate cell line based on their stable retention of GFP labeling after long-term proliferation and differentiation in vivo.
Using a two-photon laser scanning confocal microscopy platform, we first detected GFP expression in the MSCs at different healing stages (3, 5, 7, 14, 21 , and 28 days after transplantation). The results showed that few exogenous GFP + -MSCs were detected in the wound sites, and the numbers were not significantly different from our result using transfected MSCs (data not shown). To confirm this, quantitative measurement techniques were used to analyze the GFP expression in different samples. PCR and sequencing of the GFP gene revealed there were almost no exogenous MSCs or differentiated cells derived from the GFP+-MSCs that survived in the regenerative tissues after 14 days (Fig. 6 ). Western blotting confirmed this result (Fig. 5) . Therefore, we focused on the time frame of 1 day to 2 weeks to investigate the functional mechanism of the exogenous MSCs in tissue regeneration. Thus, the wound healing process based on MSC therapy would be analogous to the natural healing process after 2 weeks.
Remarkably, our immunofluorescence analysis showed that GFP was continually expressed in VSMCs and fibroblasts until day 7 of wound healing. After 2 weeks, the wound was closed, and there was very limited expression of green fluorescent protein, as recent studies have indicated that the life expectancy of MSCs is not long after transplantation [40, 41] . Consistent with our immunofluorescence assay, VSMCs and fibroblasts derived from exogenous bone marrow cells were transient during the course of wound healing [42] . These data suggest that MSCs may not be able to provide long-term self-renewal of VSMCs and fibroblast cells. After application of MSCs for wound treatment, compared with control group, a significant increase in α-SMA + -cells and VIM + -cells was shown in the wound, and these cells are relevant to vascular regeneration and collagen fiber structural remodeling. Although MSCs have multi-differentiation potential, they have been suggested to play a role in damaged tissue by differentiating into tissue cells instead of dysfunctional cells [43] . However, we found that the direct effects of exogenous cells on wound healing were limited. Previous studies showed that implanted MSCs exerted beneficial effects during skin wound repair and regeneration by accelerating wound healing, promoting the formation of granulation tissue and new blood vessels, regulating ECM remodeling, etc. More importantly, these beneficial effects seemed to be mediated through paracrine effects [44] . MSCs can attract macrophages, VSMCs and other types of cells to the wound site to release a variety of angiogenic factors involved in tissue repair [45, 46] . MSCs stimulate the release of paracrine factors, thus playing a role in the paracrine mechanism, thereby inducing the function of endogenous tissue cells [47, 48] . Our results are also consistent with these conclusions (Fig. 7A, and Fig. 8A ). It seemed that endogenous functional cells recruited from the initial exogenous MSCs still played a role in wound healing after the disappearance of the MSCs. Notably, the cell factors VIM and α-SMA were mainly produced by endogenous VSMCs and fibroblasts, which suggests that the implanted MSCs stimulated the production of paracrine factors released at the wound site, improving skin regeneration. It remains unclear why the implanted MSCs disappeared. The mechanisms involved in the decline and even death of stem cells are not fully understood. Most transplanted MSCs are easily lost, which may be caused by the ischemic environment in the body. The lack of blood and oxygen supply in the damaged area is also a possible cause of cell death [49] . However, a small portion of MSCs are able to temporarily escape from death, migrate to the injured site, and successfully differentiate into functional cells to participate in tissue repair [50] . Another possible route is that MSCs can quickly migrate to the damaged site, affecting other cells through paracrine effects, and participate in the process of tissue repair and immune regulation. Future studies on the intermolecular interactions between donor stem cells and host tissues will lead to the better use of MSCs for therapeutic applications and improved endogenous repair with stimulation by exogenous stem cells in combination therapies. Although the application of stem cell therapy in wound repair has generally been accepted, much work is required for the application of stem cells in therapies for patients with skin trauma.
In conclusion, the results of the present study provide powerful evidence that transplanting MSCs seeded on ADM scaffolds may be a promising cell-based therapeutic strategy for the treatment of skin wounds. We suggest that MSCs exert their effects on cutaneous wound healing from 1 day to 2 weeks after MSC transplantation. Further work is required to understand how MSCs respond to the host environment and to improve the survival and functional effect of MSCs in wound healing. 
